Antares Pharma: Q4 Earnings Snapshot

March 3, 2022 GMT

EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Thursday reported fourth-quarter net income of $32.7 million.

On a per-share basis, the Ewing, New Jersey-based company said it had net income of 19 cents. Earnings, adjusted for pretax gains, came to 2 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share.

The drugmaker posted revenue of $48.7 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $46.3 million.

For the year, the company reported profit of $46.3 million, or 26 cents per share. Revenue was reported as $184 million.

Antares Pharma expects full-year revenue in the range of $200 million to $220 million.

The company’s shares closed at $3.54. A year ago, they were trading at $4.06.



This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ATRS at